Sign in
4

Changes in Ownership

Lipocine Inc. Filed Acc 0001638599-19-000608

Options or other derivatives

  • Director acquired 10,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Fink Jeffrey Arvin Director 2019-06-12 Grant or award · Stock Option (Right to Buy) +10,000 $1.68 $16,800 10,000 D
Loading xslF345X03/doc4_6154.xml…